Loading...

We've got a brand new version of Simply Wall St! Try it out

TransCanna Holdings

CNSX:TCAN
Snowflake Description

Fair value with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
TCAN
CNSX
CA$35M
Market Cap
  1. Home
  2. CA
  3. Healthcare
Company description

TransCanna Holdings Inc., through its subsidiaries, engages in the management of transportation and distribution services to the cannabis industry in the United States. The last earnings update was 47 days ago. More info.


Add to Portfolio Compare Print
  • TransCanna Holdings has significant price volatility in the past 3 months.
TCAN Share Price and Events
7 Day Returns
0%
CNSX:TCAN
1.6%
CA Healthcare
1.2%
CA Market
1 Year Returns
-
CNSX:TCAN
-2%
CA Healthcare
-0.2%
CA Market
TCAN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
TransCanna Holdings (TCAN) 0% 8.4% -79.2% - - -
CA Healthcare 1.6% 0.5% -9.4% -2% -15.3% 15.5%
CA Market 1.2% 4.2% 1.5% -0.2% 8.4% 1.8%
1 Year Return vs Industry and Market
  • No trading data on TCAN.
  • No trading data on TCAN.
Price Volatility
Industry
5yr Volatility vs Market

TCAN Value

 Is TransCanna Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of TransCanna Holdings to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for TransCanna Holdings.

CNSX:TCAN Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 6.9%
Perpetual Growth Rate 10-Year CA Government Bond Rate 1.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for CNSX:TCAN
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CA Govt Bond Rate 1.9%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.63
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.628 (1 + (1- 26.5%) (25.99%))
0.831
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.83
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.95% + (0.831 * 5.96%)
6.9%

Discounted Cash Flow Calculation for CNSX:TCAN using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for TransCanna Holdings is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

CNSX:TCAN DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (CAD, Millions) Source Present Value
Discounted (@ 6.9%)
2020 18.35 Analyst x1 17.16
2021 40.81 Analyst x1 35.71
2022 61.02 Est @ 49.52% 49.95
2023 82.53 Est @ 35.25% 63.20
2024 103.37 Est @ 25.26% 74.05
2025 122.25 Est @ 18.26% 81.92
2026 138.59 Est @ 13.37% 86.88
2027 152.37 Est @ 9.94% 89.36
2028 163.87 Est @ 7.54% 89.90
2029 173.48 Est @ 5.86% 89.03
Present value of next 10 years cash flows CA$677.00
CNSX:TCAN DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= CA$173.48 × (1 + 1.95%) ÷ (6.9% – 1.95%)
CA$3,571.64
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= CA$3,571.64 ÷ (1 + 6.9%)10
CA$1,832.93
CNSX:TCAN Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= CA$677.00 + CA$1,832.93
CA$2,509.93
Equity Value per Share
(CAD)
= Total value / Shares Outstanding
= CA$2,509.93 / 34.11
CA$73.58
CNSX:TCAN Discount to Share Price
Calculation Result
Value per share (CAD) From above. CA$73.58
Current discount Discount to share price of CA$1.03
= -1 x (CA$1.03 - CA$73.58) / CA$73.58
98.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price TransCanna Holdings is available for.
Intrinsic value
>50%
Share price is CA$1.03 vs Future cash flow value of CA$73.58
Current Discount Checks
For TransCanna Holdings to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • TransCanna Holdings's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • TransCanna Holdings's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for TransCanna Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are TransCanna Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:TCAN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-05-31) in CAD CA$-0.40
CNSX:TCAN Share Price ** CNSX (2019-09-13) in CAD CA$1.03
Canada Healthcare Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Companies 55.38x
Canada Market PE Ratio Median Figure of 538 Publicly-Listed Companies 14.15x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of TransCanna Holdings.

CNSX:TCAN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:TCAN Share Price ÷ EPS (both in CAD)

= 1.03 ÷ -0.40

-2.59x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • TransCanna Holdings is loss making, we can't compare its value to the CA Healthcare industry average.
  • TransCanna Holdings is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does TransCanna Holdings's expected growth come at a high price?
Raw Data
CNSX:TCAN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -2.59x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
108.3%per year
North America Healthcare Industry PEG Ratio Median Figure of 48 Publicly-Listed Healthcare Companies 1.76x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.98x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for TransCanna Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on TransCanna Holdings's assets?
Raw Data
CNSX:TCAN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-05-31) in CAD CA$0.76
CNSX:TCAN Share Price * CNSX (2019-09-13) in CAD CA$1.03
Canada Healthcare Industry PB Ratio Median Figure of 23 Publicly-Listed Healthcare Companies 2.29x
Canada Market PB Ratio Median Figure of 2,452 Publicly-Listed Companies 1.44x
CNSX:TCAN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:TCAN Share Price ÷ Book Value per Share (both in CAD)

= 1.03 ÷ 0.76

1.36x

* Primary Listing of TransCanna Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • TransCanna Holdings is good value based on assets compared to the CA Healthcare industry average.
X
Value checks
We assess TransCanna Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. TransCanna Holdings has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

TCAN Future Performance

 How is TransCanna Holdings expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
108.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is TransCanna Holdings expected to grow at an attractive rate?
  • TransCanna Holdings's earnings growth is expected to exceed the low risk savings rate of 1.9%.
Growth vs Market Checks
  • TransCanna Holdings's earnings growth is expected to exceed the Canada market average.
  • Unable to compare TransCanna Holdings's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:TCAN Future Growth Rates Data Sources
Data Point Source Value (per year)
CNSX:TCAN Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 108.3%
Canada Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 37.9%
Canada Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 17.9%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:TCAN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:TCAN Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-11-30 141 42 38 1
2020-11-30 74 19 20 1
2019-11-30 0 -4 -7 1
2019-09-15
CNSX:TCAN Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-05-31 -4 -7
2019-02-28 -2 -4
2018-11-30 -1 -2
2017-11-30 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • TransCanna Holdings's earnings are expected to grow significantly at over 20% yearly.
  • Unable to determine if TransCanna Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:TCAN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from TransCanna Holdings Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:TCAN Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-11-30 1.18 1.18 1.18 1.00
2020-11-30 0.62 0.62 0.62 1.00
2019-11-30 -0.27 -0.27 -0.27 1.00
2019-09-15
CNSX:TCAN Past Financials Data
Date (Data in CAD Millions) EPS *
2019-05-31 -0.40
2019-02-28 -0.30
2018-11-30 -0.21
2017-11-30 -11.66

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if TransCanna Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess TransCanna Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
TransCanna Holdings has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

TCAN Past Performance

  How has TransCanna Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare TransCanna Holdings's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • TransCanna Holdings does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare TransCanna Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare TransCanna Holdings's 1-year growth to the North America Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
TransCanna Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from TransCanna Holdings Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:TCAN Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-05-31 -6.57 5.52 0.04
2019-02-28 -3.71 2.60 0.61
2018-11-30 -2.16 1.34 0.61
2017-11-30 -2.30 2.19

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if TransCanna Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if TransCanna Holdings has efficiently used its assets last year compared to the CA Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if TransCanna Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess TransCanna Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
TransCanna Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

TCAN Health

 How is TransCanna Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up TransCanna Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • TransCanna Holdings's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • TransCanna Holdings has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of TransCanna Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from TransCanna Holdings Company Filings, last reported 3 months ago.

CNSX:TCAN Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-05-31 24.02 9.13 2.18
2019-02-28 1.70 0.00 1.05
2018-11-30 -0.25 0.39 0.07
2017-11-30 0.15 0.00 0.08
  • TransCanna Holdings's level of debt (38%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if TransCanna Holdings's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • TransCanna Holdings has less than a year of cash runway based on current free cash flow.
  • Unable to confirm if TransCanna Holdings has at least 1 year of cash runway based on growing free cash flows without relevant data.
X
Financial health checks
We assess TransCanna Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. TransCanna Holdings has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

TCAN Dividends

 What is TransCanna Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from TransCanna Holdings dividends.
If you bought CA$2,000 of TransCanna Holdings shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate TransCanna Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate TransCanna Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:TCAN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
North America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 25 Stocks 1.6%
Canada Market Average Dividend Yield Market Cap Weighted Average of 333 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

CNSX:TCAN Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
2021-11-30
2020-11-30
2019-11-30
2019-09-15

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as TransCanna Holdings has not reported any payouts.
  • Unable to verify if TransCanna Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of TransCanna Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as TransCanna Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess TransCanna Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can TransCanna Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. TransCanna Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

TCAN Management

 What is the CEO of TransCanna Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Steve Giblin
TENURE AS CEO 0 years
CEO Bio

Mr. Stephen Giblin, also known as Steve, has been a President & CEO of TransCanna Holdings Inc. since September 2019 and serves as its Director since March 12, 2019. Mr. Giblin is an accomplished leader in the Global hospitality, technology and real estate industries with a demonstrated track record of value creation. Mr. Giblin has strong C suite relationships with Marriott, Hilton, and Radisson brands and he managed the Silverbirch and Delta hotel real estate portfolios for the British Columbia Investment Management Corporation. He has worked closely with other companies including established brands like that of Bentall Kennedy, Great West Life and general contractors, Ellis Don, PCL and Bird.

CEO Compensation
  • Insufficient data for Steve to compare compensation growth.
  • Insufficient data for Steve to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team

Steve Giblin

TITLE
President

Greg Ball

TITLE
Chief Financial Officer
AGE
59

Tanya Pascua

TITLE
Sales Director
Board of Directors

Arni Johannson

TITLE
Chairman

Steve Giblin

TITLE
President
TENURE
0.5 yrs

Ian Klassen

TITLE
Director
AGE
52
TENURE
0.1 yrs

Jim Pakulis

TITLE
Director
AGE
55
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by TransCanna Holdings individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
03. Sep 19 Buy Arni Johannson Individual 03. Sep 19 03. Sep 19 10,000 CA$0.85 CA$8,500
25. Aug 19 Buy Arni Johannson Individual 23. Aug 19 23. Aug 19 5,000 CA$0.75 CA$3,750
15. Aug 19 Buy Arni Johannson Individual 14. Aug 19 14. Aug 19 30,000 CA$1.15 CA$33,840
15. Aug 19 Sell Greg Ball Individual 12. Aug 19 12. Aug 19 -3,000 CA$1.13 CA$-3,290
04. Aug 19 Buy Arni Johannson Individual 31. Jul 19 31. Jul 19 10,000 CA$1.29 CA$12,900
23. Jul 19 Buy Arni Johannson Individual 23. Jul 19 23. Jul 19 5,000 CA$1.40 CA$7,000
23. Jul 19 Buy Arni Johannson Individual 22. Jul 19 22. Jul 19 5,000 CA$1.40 CA$7,000
15. Jul 19 Buy Arni Johannson Individual 07. Jun 19 07. Jun 19 35,000 CA$5.00 CA$175,000
02. Jul 19 Sell Greg Ball Individual 26. Jun 19 26. Jun 19 -2,000 CA$4.33 CA$-8,603
25. Jun 19 Sell Greg Ball Individual 24. Jun 19 24. Jun 19 -1,000 CA$4.69 CA$-4,690
24. Jun 19 Sell Greg Ball Individual 20. Jun 19 20. Jun 19 -2,000 CA$5.15 CA$-10,300
19. Jun 19 Sell Greg Ball Individual 18. Jun 19 19. Jun 19 -4,000 CA$5.15 CA$-20,250
28. May 19 Sell Greg Ball Individual 24. May 19 24. May 19 -2,000 CA$6.04 CA$-12,080
15. May 19 Sell Greg Ball Individual 10. May 19 13. May 19 -4,000 CA$7.15 CA$-27,942
21. Mar 19 Sell Greg Ball Individual 15. Mar 19 15. Mar 19 -5,000 CA$2.60 CA$-12,988
09. Feb 19 Buy Arni Johannson Individual 04. Feb 19 04. Feb 19 4,000 CA$2.43 CA$9,720
X
Management checks
We assess TransCanna Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. TransCanna Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

TCAN News

Simply Wall St News

TCAN Company Info

Description

TransCanna Holdings Inc., through its subsidiaries, engages in the management of transportation and distribution services to the cannabis industry in the United States. It provides branding, marketing, transportation, and distribution of cannabis related products for state-licensed operators involved in the cultivation, manufacture, and sale of cannabis in California. The company was founded in 2017 and is headquartered in Vancouver, Canada.

Details
Name: TransCanna Holdings Inc.
TCAN
Exchange: CNSX
Founded: 2017
CA$35,134,367
34,111,036
Website: http://www.transcanna.com
Address: TransCanna Holdings Inc.
1130 West Pender Street,
Suite 820,
Vancouver,
British Columbia, V6E 4A4,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX TCAN Common Shares Canadian National Stock Exchange CA CAD 09. Jan 2019
OTCPK TCNA.F Common Shares Pink Sheets LLC US USD 09. Jan 2019
DB TH8 Common Shares Deutsche Boerse AG DE EUR 09. Jan 2019
Number of employees
Current staff
Staff numbers
0
TransCanna Holdings employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/15 01:38
End of day share price update: 2019/09/13 00:00
Last estimates confirmation: 2019/07/03
Last earnings filing: 2019/07/30
Last earnings reported: 2019/05/31
Last annual earnings reported: 2018/11/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.